These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 17519645)
1. Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study. Barbui C; Biancosino B; Esposito E; Marmai L; Donà S; Grassi L Int Clin Psychopharmacol; 2007 Jul; 22(4):221-5. PubMed ID: 17519645 [TBL] [Abstract][Full Text] [Related]
2. Determinants of antipsychotic polypharmacy in psychiatric inpatients: a prospective study. Biancosino B; Barbui C; Marmai L; Donà S; Grassi L Int Clin Psychopharmacol; 2005 Nov; 20(6):305-9. PubMed ID: 16192838 [TBL] [Abstract][Full Text] [Related]
3. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals]. Bret P; Bret MC; Queuille E Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381 [TBL] [Abstract][Full Text] [Related]
4. Patient characteristics and process factors associated with antipsychotic polypharmacy in a nationwide sample of psychiatric inpatients in Italy. Santone G; Bellantuono C; Rucci P; Picardi A; Preti A; de Girolamo G Pharmacoepidemiol Drug Saf; 2011 May; 20(5):441-9. PubMed ID: 21523847 [TBL] [Abstract][Full Text] [Related]
5. Use of atypical antipsychotic medications in adolescent psychiatric inpatients: a comparison with inpatients who did not receive antipsychotic medications during their stay. Pogge DL; Young K; Insalaco B; Harvey PD Int J Clin Pract; 2007 Jun; 61(6):896-902. PubMed ID: 17504351 [TBL] [Abstract][Full Text] [Related]
6. Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999-2002. Mirandola M; Andretta M; Corbari L; Sorio A; Nosè M; Barbui C Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):412-20. PubMed ID: 16287199 [TBL] [Abstract][Full Text] [Related]
7. Patterns of clinical use of antipsychotics in hospitalized psychiatric patients. Mauri MC; Regispani F; Beraldo S; Volonteri LS; Ferrari VM; Fiorentini A; Invernizzi G Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):957-63. PubMed ID: 16051409 [TBL] [Abstract][Full Text] [Related]
8. Prescribing for inpatients with schizophrenia: an international multi-center comparative study. Bitter I; Chou JC; Ungvari GS; Tang WK; Xiang Z; Iwanami A; Gaszner P Pharmacopsychiatry; 2003 Jul; 36(4):143-9. PubMed ID: 12905100 [TBL] [Abstract][Full Text] [Related]
9. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003. Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060 [TBL] [Abstract][Full Text] [Related]
10. Clinical and social determinants of antipsychotic polypharmacy for Chinese patients with schizophrenia. Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS Pharmacopsychiatry; 2007 Mar; 40(2):47-52. PubMed ID: 17447172 [TBL] [Abstract][Full Text] [Related]
11. A study of polypharmacy with second generation antipsychotics in patients with severe and persistent mental illness. Megna JL; Kunwar AR; Mahlotra K; Sauro MD; Devitt PJ; Rashid A J Psychiatr Pract; 2007 Mar; 13(2):129-37. PubMed ID: 17414692 [TBL] [Abstract][Full Text] [Related]
12. Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison. Roh D; Chang JG; Kim CH; Cho HS; An SK; Jung YC Aust N Z J Psychiatry; 2014 Jan; 48(1):52-60. PubMed ID: 23671214 [TBL] [Abstract][Full Text] [Related]
13. Associations between adherence to guidelines for antipsychotic dose and health status, side effects, and patient care experiences. Dickey B; Normand SL; Eisen S; Hermann R; Cleary P; Cortés D; Ware N Med Care; 2006 Sep; 44(9):827-34. PubMed ID: 16932134 [TBL] [Abstract][Full Text] [Related]
14. Antipsychotic medication utilization trends among Texas veterans: 1997-2002. Yang M; Barner JC; Lawson KA; Rascati KL; Wilson JP; Crismon ML; Worchel J; Mascarenas CA Ann Pharmacother; 2008 Sep; 42(9):1229-38. PubMed ID: 18682544 [TBL] [Abstract][Full Text] [Related]
16. Clinical correlates of antipsychotic polytherapy in patients with schizophrenia in Singapore. Sim K; Su A; Chan YH; Shinfuku N; Kua EH; Tan CH Psychiatry Clin Neurosci; 2004 Jun; 58(3):324-9. PubMed ID: 15149301 [TBL] [Abstract][Full Text] [Related]
17. The prescribing pattern of a new antipsychotic: a descriptive study of aripiprazole for psychiatric in-patients. Andersen SE; Johansson M; Manniche C Basic Clin Pharmacol Toxicol; 2008 Jul; 103(1):75-81. PubMed ID: 18346047 [TBL] [Abstract][Full Text] [Related]
19. Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatients. Procyshyn RM; Honer WG; Wu TK; Ko RW; McIsaac SA; Young AH; Johnson JL; Barr AM J Clin Psychiatry; 2010 May; 71(5):566-73. PubMed ID: 20361903 [TBL] [Abstract][Full Text] [Related]
20. Antipsychotic polypharmacy among patients admitted to a geriatric psychiatry unit. Dolder CR; McKinsey J J Psychiatr Pract; 2011 Sep; 17(5):368-74. PubMed ID: 21926533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]